Castle Biosciences (NASDAQ:CSTL) Price Target Lowered to $37.00 at Canaccord Genuity Group
Castle Biosciences (NASDAQ:CSTL – Get Free Report) had its target price cut by stock analysts at Canaccord Genuity Group from $42.00 to $37.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 117.01% from the company’s […]
Castle Biosciences (NASDAQ:CSTL – Get Free Report) had its target price cut by stock analysts at Canaccord Genuity Group from $42.00 to $37.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 117.01% from the company’s […]
